Melanie Sena is community editor of Pharmaceutical Technology.
Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.
Johnson&Johnson will open a network of partnering offices across the UK.
GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.
Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.
BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.
LSNE appoints Shawn Cain as COO, a new position within the company.
Catalent opens clinical-trial supply facility in Shanghai, China.
Almac releases an enhanced third-party logistics customer billing application.
Pure MHC and Catalent sign an agreement to develop RL21A using Catalent's GPEx technology.